Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

AID Life Science Holdings Limited

*

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 8088)

DISCLOSEABLE TRANSACTION DISPOSAL OF LISTED SECURITIES

On 4 December 2018, the Group disposed on-market of a total of 410,000,000 HMV Shares in a series of transactions at the average price of approximately HK$0.02415 per HMV Share for an aggregate gross sale proceeds of approximately HK$9,900,000 (excluding transaction costs).

The Disposal constitutes a discloseable transaction of the Company as one of the applicable percentage ratios exceeds 5% but is less than 25%, and is therefore subject to the reporting and announcement requirements under the GEM Listing Rules.

THE DISPOSAL

On 4 December 2018, the Group disposed on-market of a total of 410,000,000 HMV Shares in a series of transactions at the average price of approximately HK$0.02415 per HMV Share for an aggregate gross sale proceeds of approximately HK$9,900,000 (excluding transaction costs).

As the Disposal was made on the market, the Company is not aware of the identities of the purchasers of the HMV Shares. To the best of the knowledge, information and belief of the Directors, having made all reasonable enquiries, each of the purchasers of the HMV Shares and their ultimate beneficial owners are third parties independent of the Company and its connected persons.

*

For identification purpose only

Assets disposed of

The Group disposed of a total of 410,000,000 HMV Shares, representing approximately 3.02% of the issued share capital of HMV based on the 13,598,568,971 HMV Shares in issue as at 3 December 2018 according to the Next Day Disclosure Return of HMV dated 3 December 2018. Before the Disposal, the Group held a total of 2,804,938,356 HMV Shares. After the Disposal, the Group holds a total of 2,394,938,356 HMV Shares.

Consideration

The aggregate gross sale proceeds of the Disposal is approximately HK$9,900,000 (excluding transaction costs), which is receivable in cash on settlement, being the second business day after the date of Disposal. The consideration for the Disposal represented the market price of the HMV Shares at the time of the Disposal.

INFORMATION OF HMV

HMV is a company incorporated in Bermuda with limited liability whose shares are listed on GEM of the Stock Exchange (stock code: 8078). HMV is an investment holding company and its subsidiaries are principally engaged in the distribution and production of films, television programs and music production, artiste management services, retail and on-line video streaming businesses.

The following information is extracted from the 2017-2018 annual report of HMV:

Revenue

Profit before taxation

Profit after taxation credit

Net asset value

REASONS FOR AND BENEFITS OF THE DISPOSAL

For the year ended

For the year ended

30 June 2018

30 June 2017

HK$'000

HK$'000

608,251

561,388

1,747

14,819

6,063

21,409

2,478,245

2,581,169

The Group is engaged in the business of strategic investment.

The Board having noted the unusual plunge in the trading price of HMV Shares during the morning trading session on 4 December 2018 decided to sell part of the HMV Shares to cut losses in order to limit a potential loss should the price of the HMV Shares fall further. As a result of the Disposal, the Group is expected to recognise a loss of approximately HK$77,430,000 which is calculated on the basis of the difference between the market value on 30 September 2018 (last quarterly report published on 12 November 2018) and the disposal price (exclusive of transaction costs) of the HMV Shares. The net proceeds of the Disposal will be applied as the Group's general working capital.

The Disposal was made at market price and the Board is of the view that the Disposal will enhance the liquidity of the Company and was fair and reasonable and is on normal commercial terms and is in the interests of the Company and the Shareholders as a whole.

IMPLICATION UNDER THE LISTING RULES

As one of the applicable percentage ratios (as defined in the GEM Listing Rules) in respect of the Disposal is more than 5% but less than 25%, the Disposal constitutes a discloseable transaction of the Company under the GEM Listing Rules and is therefore subject to the reporting and announcement requirements under the GEM Listing Rules.

DEFINITIONS

In this announcement, unless the context otherwise requires, the following terms shall have the following meanings:

''Board''

the board of Directors

''Company''

AID Life Science Holdings Company Limited (Stock code:

8088), a company incorporated in the Cayman Islands with

limited liability and the Shares of which are listed on GEM

of the Stock Exchange

''connected person(s)''

has the meaning ascribed thereto under the GEM Listing

Rules

''Director(s)''

the director(s) of the Company

''Disposal''

the disposal by the Company of a total of 410,000,000 HMV

Shares on the market on 4 December 2018 for a total

consideration of approximately HK$9,900,000

''GEM Listing Rules''

the Rules Governing the Listing of Securities on GEM of

the Stock Exchange

''Group''

the Company and its subsidiaries

''HK$''

Hong Kong dollar(s), the lawful currency of Hong Kong

''HMV''

HMV Digital China Group Limited, a company incorporated

in Bermuda with limited liability whose shares are listed on

GEM of the Stock Exchange (stock code: 8078)

''HMV Share(s)''

ordinary share(s) with a nominal value of HK$0.01 each in

the share capital of HMV

''Hong Kong''

the Hong Kong Special Administrative Region of the

People's Republic of China

''Share(s)''

ordinary share(s) of US$0.0001 each in the share capital of

the Company

''Shareholder(s)''

holder(s) of the Shares

''Stock Exchange''

The Stock Exchange of Hong Kong Limited

''US$''

United Sates dollar(s), the lawful currency of the United

States of America

''%''

per cent.

Hong Kong, 4 December 2018

By order of the Board

AID Life Science Holdings Limited

Wu King Shiu Kelvin Chairman and Chief Executive Officer

As at the date of this announcement, the Board comprises four executive Directors, namely Wu King Shiu, Kelvin, Chan Suet Ngan, Hu Kenneth and Qian Alexandra Gaochuan; one non-executive Director, namely Xu Haohao; and three independent non-executive Directors, namely Fong Janie, Yuen Kwok On and Matsumoto Hitoshi.

This announcement, for which the Directors collectively and individually accept full responsibility, includes particulars given in compliance with the GEM Listing Rules for the purpose of giving information with regard to the Company. The Directors, having made all reasonable enquiries, confirm that, to the best of their knowledge and belief (i) the information contained in this announcement is accurate and complete in all material respects and not misleading or deceptive; and (ii) there are no other matters the omission of which would make any statement in this announcement misleading.

This announcement will remain on the GEM website atwww.hkgem.comon the ''Latest Company Announcements'' page for at least 7 days from the date of its posting and on the website of the Company atwww.8088inc.com.

Attachments

  • Original document
  • Permalink

Disclaimer

Healthoo International Technology Holdings Limited published this content on 05 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 05 December 2018 09:31:08 UTC